Skip to main content
Top
Published in: Virology Journal 1/2017

Open Access 01-12-2017 | Research

Maternal antibodies protect offspring from severe influenza infection and do not lead to detectable interference with subsequent offspring immunization

Authors: Joan E. M. van der Lubbe, Jessica Vreugdenhil, Sarra Damman, Joost Vaneman, Jaco Klap, Jaap Goudsmit, Katarina Radošević, Ramon Roozendaal

Published in: Virology Journal | Issue 1/2017

Login to get access

Abstract

Background

Various studies have shown that infants under the age of 6 months are especially vulnerable for complications due to influenza. Currently there are no vaccines licensed for use in this age group. Vaccination of pregnant women during the last trimester, recommended by the WHO as protective measure for this vulnerable female population, may provide protection of newborns at this early age. Although it has been observed that maternal vaccination can passively transfer protection, maternal antibodies could possibly also interfere with subsequent active vaccination of the offspring.

Methods

Using a mouse model, we evaluated in depth the ability of maternal influenza vaccination to protect offspring and the effect of maternal immunization on the subsequent influenza vaccination of the offspring. By varying the regimen of maternal immunization we explored the impact of different levels of maternal antibodies on the longevity of these antibodies in their progeny. We subsequently assessed to what extent maternal antibodies can mediate direct protection against influenza in their offspring, and whether these antibodies interfere with protection induced by active vaccination of the offspring.

Results

The number of immunizations of pregnant mice correlates to the level and longevity of maternal antibodies in the offspring. When these antibodies are present at time of influenza challenge they protect offspring against lethal influenza challenge, even in the absence of detectable HAI titers. Moreover, no detectable interference of passively-transferred maternal antibodies on the subsequent vaccination of the offspring was observed.

Conclusion

In the absence of a licensed influenza vaccine for young children, vaccination of pregnant women is a promising measure to provide protection of young infants against severe influenza infection.
Appendix
Available only for authorised users
Literature
1.
go back to reference Poehling KA, et al. The underrecognized burden of influenza in young children. N Engl J Med. 2006;355(1):31–40.CrossRefPubMed Poehling KA, et al. The underrecognized burden of influenza in young children. N Engl J Med. 2006;355(1):31–40.CrossRefPubMed
2.
go back to reference Bhat N, et al. Influenza-associated deaths among children in the United States, 2003-2004. N Engl J Med. 2005;353(24):2559–67.CrossRefPubMed Bhat N, et al. Influenza-associated deaths among children in the United States, 2003-2004. N Engl J Med. 2005;353(24):2559–67.CrossRefPubMed
3.
go back to reference Chiu SS, et al. Population-based hospitalization incidence of respiratory viruses in community-acquired pneumonia in children younger than 5 years of age. Influenza Other Respir Viruses. 2014;8(6):626–7.CrossRefPubMedPubMedCentral Chiu SS, et al. Population-based hospitalization incidence of respiratory viruses in community-acquired pneumonia in children younger than 5 years of age. Influenza Other Respir Viruses. 2014;8(6):626–7.CrossRefPubMedPubMedCentral
4.
go back to reference Dominguez A, Godoy P, Torner N. The Effectiveness of Influenza Vaccination in Different Groups. Expert Rev Vaccines. 2016;15(6):751–64.CrossRefPubMed Dominguez A, Godoy P, Torner N. The Effectiveness of Influenza Vaccination in Different Groups. Expert Rev Vaccines. 2016;15(6):751–64.CrossRefPubMed
5.
go back to reference Jamieson DJ, et al. H1N1 2009 influenza virus infection during pregnancy in the USA. Lancet. 2009;374(9688):451–8.CrossRefPubMed Jamieson DJ, et al. H1N1 2009 influenza virus infection during pregnancy in the USA. Lancet. 2009;374(9688):451–8.CrossRefPubMed
6.
go back to reference Siston AM, et al. Pandemic 2009 influenza a(H1N1) virus illness among pregnant women in the United States. JAMA. 2010;303(15):1517–25.CrossRefPubMed Siston AM, et al. Pandemic 2009 influenza a(H1N1) virus illness among pregnant women in the United States. JAMA. 2010;303(15):1517–25.CrossRefPubMed
7.
go back to reference Sham PC, et al. Schizophrenia following pre-natal exposure to influenza epidemics between 1939 and 1960. Br J Psychiatry. 1992;160:461–6.CrossRefPubMed Sham PC, et al. Schizophrenia following pre-natal exposure to influenza epidemics between 1939 and 1960. Br J Psychiatry. 1992;160:461–6.CrossRefPubMed
8.
go back to reference Mednick SA, et al. Adult schizophrenia following prenatal exposure to an influenza epidemic. Arch Gen Psychiatry. 1988;45(2):189–92.CrossRefPubMed Mednick SA, et al. Adult schizophrenia following prenatal exposure to an influenza epidemic. Arch Gen Psychiatry. 1988;45(2):189–92.CrossRefPubMed
9.
10.
12.
go back to reference Chiu SS, et al. Influenza-related hospitalizations among children in Hong Kong. N Engl J Med. 2002;347(26):2097–103.CrossRefPubMed Chiu SS, et al. Influenza-related hospitalizations among children in Hong Kong. N Engl J Med. 2002;347(26):2097–103.CrossRefPubMed
13.
go back to reference Izurieta HS, et al. Influenza and the rates of hospitalization for respiratory disease among infants and young children. N Engl J Med. 2000;342(4):232–9.CrossRefPubMed Izurieta HS, et al. Influenza and the rates of hospitalization for respiratory disease among infants and young children. N Engl J Med. 2000;342(4):232–9.CrossRefPubMed
14.
go back to reference Neuzil KM, et al. The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children. N Engl J Med. 2000;342(4):225–31.CrossRefPubMed Neuzil KM, et al. The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children. N Engl J Med. 2000;342(4):225–31.CrossRefPubMed
15.
go back to reference Glezen WP, et al. Influenza virus infections in infants. Pediatr Infect Dis J. 1997;16(11):1065–8.CrossRefPubMed Glezen WP, et al. Influenza virus infections in infants. Pediatr Infect Dis J. 1997;16(11):1065–8.CrossRefPubMed
16.
go back to reference Neuzil KM, et al. Burden of interpandemic influenza in children younger than 5 years: a 25-year prospective study. J Infect Dis. 2002;185(2):147–52.CrossRefPubMed Neuzil KM, et al. Burden of interpandemic influenza in children younger than 5 years: a 25-year prospective study. J Infect Dis. 2002;185(2):147–52.CrossRefPubMed
18.
go back to reference Sweet C, et al. Production of passive immunity in neonatal ferrets following maternal vaccination with killed influenza a virus vaccines. Immunology. 1987;60(1):83–9.PubMedPubMedCentral Sweet C, et al. Production of passive immunity in neonatal ferrets following maternal vaccination with killed influenza a virus vaccines. Immunology. 1987;60(1):83–9.PubMedPubMedCentral
19.
go back to reference Renshaw HW. Influence of antibody-mediated immune suppression on clinical, viral, and immune responses to swine influenza infection. Am J Vet Res. 1975;36(1):5–13.PubMed Renshaw HW. Influence of antibody-mediated immune suppression on clinical, viral, and immune responses to swine influenza infection. Am J Vet Res. 1975;36(1):5–13.PubMed
20.
go back to reference Mbawuike IN, et al. Vaccination with inactivated influenza a virus during pregnancy protects neonatal mice against lethal challenge by influenza a viruses representing three subtypes. J Virol. 1990;64(3):1370–4.PubMedPubMedCentral Mbawuike IN, et al. Vaccination with inactivated influenza a virus during pregnancy protects neonatal mice against lethal challenge by influenza a viruses representing three subtypes. J Virol. 1990;64(3):1370–4.PubMedPubMedCentral
21.
go back to reference Hwang SD, et al. Protection of pregnant mice, fetuses and neonates from lethality of H5N1 influenza viruses by maternal vaccination. Vaccine. 2010;28(17):2957–64.CrossRefPubMed Hwang SD, et al. Protection of pregnant mice, fetuses and neonates from lethality of H5N1 influenza viruses by maternal vaccination. Vaccine. 2010;28(17):2957–64.CrossRefPubMed
22.
go back to reference Small PA Jr, et al. Influenza infection in ferrets: role of serum antibody in protection and recovery. Infect Immun. 1976;13(2):417–24.PubMedPubMedCentral Small PA Jr, et al. Influenza infection in ferrets: role of serum antibody in protection and recovery. Infect Immun. 1976;13(2):417–24.PubMedPubMedCentral
23.
go back to reference Sumaya CV, Gibbs RS. Immunization of pregnant women with influenza a/New Jersey/76 virus vaccine: reactogenicity and immunogenicity in mother and infant. J Infect Dis. 1979;140(2):141–6.CrossRefPubMed Sumaya CV, Gibbs RS. Immunization of pregnant women with influenza a/New Jersey/76 virus vaccine: reactogenicity and immunogenicity in mother and infant. J Infect Dis. 1979;140(2):141–6.CrossRefPubMed
24.
go back to reference Masurel N, et al. Haemagglutination-inhibition antibodies against influenza a and influenza B in maternal and neonatal sera. J Hyg (Lond). 1978;80(1):13–9.CrossRef Masurel N, et al. Haemagglutination-inhibition antibodies against influenza a and influenza B in maternal and neonatal sera. J Hyg (Lond). 1978;80(1):13–9.CrossRef
25.
go back to reference Reuman PD, Ayoub EM, Small PA. Effect of passive maternal antibody on influenza illness in children: a prospective study of influenza a in mother-infant pairs. Pediatr Infect Dis J. 1987;6(4):398–403.CrossRefPubMed Reuman PD, Ayoub EM, Small PA. Effect of passive maternal antibody on influenza illness in children: a prospective study of influenza a in mother-infant pairs. Pediatr Infect Dis J. 1987;6(4):398–403.CrossRefPubMed
26.
go back to reference Barber WH, Small PA Jr. Local and systemic immunity to influenza infections in ferrets. Infect Immun. 1978;21(1):221–8.PubMedPubMedCentral Barber WH, Small PA Jr. Local and systemic immunity to influenza infections in ferrets. Infect Immun. 1978;21(1):221–8.PubMedPubMedCentral
27.
go back to reference Loeffen WL, et al. Effect of maternally derived antibodies on the clinical signs and immune response in pigs after primary and secondary infection with an influenza H1N1 virus. Vet Immunol Immunopathol. 2003;92(1–2):23–35.CrossRefPubMed Loeffen WL, et al. Effect of maternally derived antibodies on the clinical signs and immune response in pigs after primary and secondary infection with an influenza H1N1 virus. Vet Immunol Immunopathol. 2003;92(1–2):23–35.CrossRefPubMed
28.
29.
go back to reference Zaman K, et al. Effectiveness of maternal influenza immunization in mothers and infants. N Engl J Med. 2008;359(15):1555–64.CrossRefPubMed Zaman K, et al. Effectiveness of maternal influenza immunization in mothers and infants. N Engl J Med. 2008;359(15):1555–64.CrossRefPubMed
30.
33.
34.
go back to reference Bischoff AL, et al. Altered Response to A(H1N1)pnd09 Vaccination in Pregnant Women: A Single Blinded Randomized Controlled Trial. PLoS One. 2013;8(4):e56700.CrossRefPubMedPubMedCentral Bischoff AL, et al. Altered Response to A(H1N1)pnd09 Vaccination in Pregnant Women: A Single Blinded Randomized Controlled Trial. PLoS One. 2013;8(4):e56700.CrossRefPubMedPubMedCentral
35.
go back to reference Reuman PD, et al. Maternal-infant transfer of influenza-specific immunity in the mouse. J Immunol. 1983;130(2):932–6.PubMed Reuman PD, et al. Maternal-infant transfer of influenza-specific immunity in the mouse. J Immunol. 1983;130(2):932–6.PubMed
36.
go back to reference Holsapple MP, West LJ, Landreth KS. Species comparison of anatomical and functional immune system development. Birth Defects Res B Dev Reprod Toxicol. 2003;68(4):321–34.CrossRefPubMed Holsapple MP, West LJ, Landreth KS. Species comparison of anatomical and functional immune system development. Birth Defects Res B Dev Reprod Toxicol. 2003;68(4):321–34.CrossRefPubMed
37.
go back to reference Schlaudecker EP, et al. Pregnancy modifies the antibody response to trivalent influenza immunization. J Infect Dis. 2012;206(11):1670–3.CrossRefPubMed Schlaudecker EP, et al. Pregnancy modifies the antibody response to trivalent influenza immunization. J Infect Dis. 2012;206(11):1670–3.CrossRefPubMed
38.
go back to reference Christian LM. Optimizing benefits of influenza virus vaccination during pregnancy: potential behavioral risk factors and interventions. Vaccine. 2014;32(25):2958–64.CrossRefPubMedPubMedCentral Christian LM. Optimizing benefits of influenza virus vaccination during pregnancy: potential behavioral risk factors and interventions. Vaccine. 2014;32(25):2958–64.CrossRefPubMedPubMedCentral
39.
go back to reference Reuman PD, et al. Maternal-infant transfer of influenza-specific immunity not detectable by haemagglutination inhibition. Microbios. 1988;54(220–221):135–47.PubMed Reuman PD, et al. Maternal-infant transfer of influenza-specific immunity not detectable by haemagglutination inhibition. Microbios. 1988;54(220–221):135–47.PubMed
41.
go back to reference Bertley FM, et al. Measles vaccination in the presence of maternal antibodies primes for a balanced humoral and cellular response to revaccination. Vaccine. 2004;23(4):444–9.CrossRefPubMed Bertley FM, et al. Measles vaccination in the presence of maternal antibodies primes for a balanced humoral and cellular response to revaccination. Vaccine. 2004;23(4):444–9.CrossRefPubMed
42.
go back to reference van Binnendijk RS, et al. Protective immunity in macaques vaccinated with live attenuated, recombinant, and subunit measles vaccines in the presence of passively acquired antibodies. J Infect Dis. 1997;175(3):524–32.CrossRefPubMed van Binnendijk RS, et al. Protective immunity in macaques vaccinated with live attenuated, recombinant, and subunit measles vaccines in the presence of passively acquired antibodies. J Infect Dis. 1997;175(3):524–32.CrossRefPubMed
43.
go back to reference Gans H, et al. Measles and mumps vaccination as a model to investigate the developing immune system: passive and active immunity during the first year of life. Vaccine. 2003;21(24):3398–405.CrossRefPubMed Gans H, et al. Measles and mumps vaccination as a model to investigate the developing immune system: passive and active immunity during the first year of life. Vaccine. 2003;21(24):3398–405.CrossRefPubMed
44.
go back to reference Benowitz I, et al. Influenza vaccine given to pregnant women reduces hospitalization due to influenza in their infants. Clin Infect Dis. 51(12):1355–61. Benowitz I, et al. Influenza vaccine given to pregnant women reduces hospitalization due to influenza in their infants. Clin Infect Dis. 51(12):1355–61.
45.
go back to reference Eick AA, et al. Maternal influenza vaccination and effect on influenza virus infection in young infants. Arch Pediatr Adolesc Med. 2011;165(2):104–11.CrossRefPubMed Eick AA, et al. Maternal influenza vaccination and effect on influenza virus infection in young infants. Arch Pediatr Adolesc Med. 2011;165(2):104–11.CrossRefPubMed
46.
go back to reference France EK, et al. Impact of maternal influenza vaccination during pregnancy on the incidence of acute respiratory illness visits among infants. Arch Pediatr Adolesc Med. 2006;160(12):1277–83.CrossRefPubMed France EK, et al. Impact of maternal influenza vaccination during pregnancy on the incidence of acute respiratory illness visits among infants. Arch Pediatr Adolesc Med. 2006;160(12):1277–83.CrossRefPubMed
47.
go back to reference Black SB, et al. Effectiveness of influenza vaccine during pregnancy in preventing hospitalizations and outpatient visits for respiratory illness in pregnant women and their infants. Am J Perinatol. 2004;21(6):333–9.CrossRefPubMed Black SB, et al. Effectiveness of influenza vaccine during pregnancy in preventing hospitalizations and outpatient visits for respiratory illness in pregnant women and their infants. Am J Perinatol. 2004;21(6):333–9.CrossRefPubMed
48.
go back to reference Puck JM, et al. Protection of infants from infection with influenza a virus by transplacentally acquired antibody. J Infect Dis. 1980;142(6):844–9.CrossRefPubMed Puck JM, et al. Protection of infants from infection with influenza a virus by transplacentally acquired antibody. J Infect Dis. 1980;142(6):844–9.CrossRefPubMed
49.
go back to reference Manske JM. Efficacy and effectiveness of maternal influenza vaccination during pregnancy: a review of the evidence. Matern Child Health J. 2014;18(7):1599–609.CrossRefPubMed Manske JM. Efficacy and effectiveness of maternal influenza vaccination during pregnancy: a review of the evidence. Matern Child Health J. 2014;18(7):1599–609.CrossRefPubMed
50.
go back to reference Niewiesk S. Maternal antibodies: clinical significance, mechanism of interference with immune responses, and possible vaccination strategies. Front Immunol. 2014;5:446.CrossRefPubMedPubMedCentral Niewiesk S. Maternal antibodies: clinical significance, mechanism of interference with immune responses, and possible vaccination strategies. Front Immunol. 2014;5:446.CrossRefPubMedPubMedCentral
51.
go back to reference Siegrist CA. Mechanisms by which maternal antibodies influence infant vaccine responses: review of hypotheses and definition of main determinants. Vaccine. 2003;21(24):3406–12.CrossRefPubMed Siegrist CA. Mechanisms by which maternal antibodies influence infant vaccine responses: review of hypotheses and definition of main determinants. Vaccine. 2003;21(24):3406–12.CrossRefPubMed
Metadata
Title
Maternal antibodies protect offspring from severe influenza infection and do not lead to detectable interference with subsequent offspring immunization
Authors
Joan E. M. van der Lubbe
Jessica Vreugdenhil
Sarra Damman
Joost Vaneman
Jaco Klap
Jaap Goudsmit
Katarina Radošević
Ramon Roozendaal
Publication date
01-12-2017
Publisher
BioMed Central
Published in
Virology Journal / Issue 1/2017
Electronic ISSN: 1743-422X
DOI
https://doi.org/10.1186/s12985-017-0787-4

Other articles of this Issue 1/2017

Virology Journal 1/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.